郭錦松醫師詳細介紹

國立陽明交通大學臨床醫學研究所 博士

國立陽明交通大學醫學系 醫學士

-迄今臺北榮民總醫院內科部內分泌新陳代謝科主治醫師

-迄今國立陽明大學醫學院醫學系 助理教授

-迄今中華民國內分泌學會監事

-迄今中華民國糖尿病衛教學會理事

-迄今台灣甲狀腺協會理事長

-美國加州大學 爾灣分校 內分泌新陳代謝科研究員

-慈濟大學醫學院內科助理教授

-大林慈濟醫院新陳代謝科主任

-國立陽明大學醫學院講師

-臺北榮民總醫院內科部內分泌新陳代謝科總醫師

-臺北榮民總醫院內科部住院醫師

糖尿病、甲狀腺疾病、血脂異常

中華民國內科專科醫師

中華民國內分泌暨新陳代謝科專科醫師

中華民國糖尿病衛教學會糖尿病衛教師

臺北市糖尿病共同照護網糖尿病認證醫師

Kuo CS, Kuo NR, Yeh YK, Lee YJ, Chuang LM, Chen HF, Chen CC, Lee CC, Hsu CC, Li HY, Ou HY, Hwu CM. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study. Lipids Health Dis. 2024 Jan 23. [IF 3.9]

Kuo CS, Chen HS. β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy. Diabetes Res Clin Pract. 2024 Aug 8. [IF 6.1]

Po-Sheng Lee, Jui-Yu Chen, Li-Hsin Pan, Chii-Min Hwu, Jen-Fan Hang, Chin-Sung Kuo. Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report. Medicine. 2024 August 23 [IF 1.3]

Li-Hsin Pan, Jen-Fan Hang, Jui-Yu Chen, Po-Sheng Lee, Yun-Kai Yeh, Tai-Jung Huang, Chii-Min Hwu, Chin-Sung Kuo. Difficulties of Pre-operative Diagnosis of Cribriform Morular Thyroid Carcinoma: A Case Report. Case Rep Endocrinol. 2024 May 28. [IF 1.1]

Lai HF, Hang JF, Kuo PC, Kuo CS, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.4]

Lai HF, Hang JF, Kuo PC, Kuo CS*, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.7]

Chen KL, Chou RH, Chang CC, Kuo CS*, Wei JH, Huang PH, Lin SJ. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study. PLoS One. 2024 Apr 11. [IF 3.7]

Shen FC, ……, Kuo CS*, …..., Sheu WH, Huang CN, Wang CY, Ou HY. Optimizing Lipid Control in Taiwanese Diabetic Patients: A Collaborative Consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators. Journal of Diabetes Investigation. 2024 Aug. [IF 3.2]

Jee-Fu Huang, ……, Chin-Sung Kuo, ……, Ming-Lung Yu. Taiwan Position Statement of Patients with Diabetes and Steatotic Liver Disease. Hepatology Communications 2024 accepted. [IF 5.6]

Chen CE, Guo JY, Chou RH, Wu CH, Kuo CS, Wei JH, Huang PH. Circulating corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients. Sci Rep. 2024 Aug 27. [IF 3.8]

Huang JF, ……, Kuo CS, ……, Yu ML. Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus. Hepatol Commun. 2024 Oct 30. [IF 5.6]